Delta Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Delta Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.57M	Sell	75,322 -917	-1%	-$53.5K	0.42%	36
2025 Q4	$4.11M	Buy	76,239 +1,441	+2%	+$69.3K	0.35%	38
2025 Q3	$3.37M	Buy	74,798 +1,155	+2%	+$53.9K	0.29%	43
2025 Q2	$3.41M	Sell	73,643 -1,881	-2%	-$92.3K	0.3%	42
2025 Q1	$4.61M	Sell	75,524 -1,782	-2%	-$104K	0.44%	35
2024 Q4	$4.37M	Sell	77,306 -2,270	-3%	-$127K	0.39%	35
2024 Q3	$4.12M	Sell	79,576 -2,185	-3%	-$103K	0.35%	36
2024 Q2	$3.4M	Sell	81,761 -4,600	-5%	-$206K	0.31%	42
2024 Q1	$4.68M	Buy	86,361 +8,897	+11%	+$453K	0.41%	38
2023 Q4	$3.97M	Buy	77,464 +5,488	+8%	+$288K	0.38%	38
2023 Q3	$4.18M	Buy	71,976 +1,590	+2%	+$97.4K	0.44%	38
2023 Q2	$4.5M	Buy	70,386 +3,072	+5%	+$206K	0.45%	38
2023 Q1	$4.67M	Buy	67,314 +2,993	+5%	+$211K	0.49%	38
2022 Q4	$4.63M	Buy	64,321 +14	+0%	+$1.06K	0.5%	38
2022 Q3	$4.57M	Buy	64,307 +150	+0.2%	+$10.9K	0.55%	37
2022 Q2	$4.94M	Sell	64,157 -1,242	-2%	-$94.6K	0.56%	35
2022 Q1	$4.78M	Sell	65,399 -283	-0.4%	-$19K	0.46%	37
2021 Q4	$4.09M	Sell	65,682 -1,282	-2%	-$75.2K	0.36%	40
2021 Q3	$3.96M	Buy	66,964 +799	+1%	+$52.6K	0.38%	35
2021 Q2	$4.42M	Buy	66,165 +582	+0.9%	+$38K	0.42%	35
2021 Q1	$4.14M	Buy	65,583 +5,752	+10%	+$358K	0.42%	35
2020 Q4	$3.71M	Buy	59,831 +2,336	+4%	+$144K	0.41%	36
2020 Q3	$3.47M	Buy	57,495 +1,978	+4%	+$119K	0.42%	36
2020 Q2	$3.26M	Buy	55,517 +2,786	+5%	+$167K	0.43%	37
2020 Q1	$2.94M	Sell	52,731 -1,630	-3%	-$99.6K	0.46%	36
2019 Q4	$3.49M	Buy	54,361 +61	+0.1%	+$3.49K	0.43%	36
2019 Q3	$2.75M	Sell	54,300 -1,878	-3%	-$88.3K	0.37%	41
2019 Q2	$2.55M	Sell	56,178 -2,078	-4%	-$96.8K	0.35%	39
2019 Q1	$2.78M	Sell	58,256 -6,949	-11%	-$346K	0.4%	39
2018 Q4	$3.39M	Sell	65,205 -2,983	-4%	-$160K	0.52%	38
2018 Q3	$4.23M	Sell	68,188 -788	-1%	-$46.8K	0.56%	36
2018 Q2	$3.82M	Sell	68,976 -2,313	-3%	-$125K	0.56%	35
2018 Q1	$4.51M	Sell	71,289 -536	-0.7%	-$34.5K	0.67%	32
2017 Q4	$4.4M	Buy	71,825 +147	+0.2%	+$9.19K	0.62%	34
2017 Q3	$4.57M	Buy	71,678 +2,937	+4%	+$171K	0.69%	34
2017 Q2	$3.83M	Buy	68,741 +962	+1%	+$52.3K	0.59%	35
2017 Q1	$3.69M	Buy	67,779 +1,587	+2%	+$87K	0.58%	35
2016 Q4	$3.87M	Buy	66,192 +1,790	+3%	+$97.9K	0.65%	34
2016 Q3	$3.47M	Buy	64,402 +720	+1%	+$46.3K	0.59%	34
2016 Q2	$4.68M	Sell	63,682 -1,250	-2%	-$88.3K	0.81%	33
2016 Q1	$4.15M	Buy	64,932 +1,210	+2%	+$76.3K	0.74%	35
2015 Q4	$4.38M	Sell	63,722 -879	-1%	-$58.1K	0.8%	33
2015 Q3	$3.82M	Buy	64,601 +1,261	+2%	+$80K	0.75%	34
2015 Q2	$4.21M	Buy	63,340 +2,880	+5%	+$190K	0.78%	33
2015 Q1	$3.9M	Buy	60,460 +1,719	+3%	+$108K	0.74%	33
2014 Q4	$3.47M	Buy	58,741 +210	+0.4%	+$11.8K	0.67%	33
2014 Q3	$3M	Buy	58,531 +2,443	+4%	+$122K	0.61%	36
2014 Q2	$2.72M	Buy	56,088 +2,680	+5%	+$132K	0.56%	36
2014 Q1	$2.77M	Buy	53,408 +1,458	+3%	+$77.6K	0.6%	36
2013 Q4	$2.76M	Buy	51,950 +490	+1%	+$25K	0.61%	37
2013 Q3	$2.38M	Buy	51,460 +179	+0.3%	+$7.86K	0.58%	37
2013 Q2	$2.29M	Buy	+51,281	New	+$2.23M	0.57%	38

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Delta Asset Management's BMY Position: Q1 2026 in Review

Delta Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q1 2026, selling an estimated $53.5K and leaving 75,322 shares worth $4.57M. The position accounts for 0.42% of the portfolio, ranked #36.

Delta Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.94M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Delta Asset Management held 75,322 shares of Bristol-Myers Squibb worth $4.57M as of Q1 2026.
Delta Asset Management sold 917 Bristol-Myers Squibb shares in Q1 2026, an estimated $53.5K.
Bristol-Myers Squibb made up 0.42% of Delta Asset Management's portfolio in Q1 2026, its #36 holding.
Delta Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Delta Asset Management's Bristol-Myers Squibb position peaked at $4.94M in Q2 2022.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Delta Asset Management's 13F filing for Q1 2026, filed 11 May 2026.